Paul Little | Chief Financial Officer |
David-Alexandre Gros | Chief Executive Officer |
Steve Perrin | President and Chief Scientific Officer |
Jeff Bornstein | Chief Medical Officer |
Pete Stavropoulos | Cantor Fitzgerald |
Nat Charoensook | SVB |
Matt Kaplan | Ladenburg Thalmann |
Greetings, and welcome to Eledon Pharmaceuticals First Quarter Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded today, May 12, 2022. I would now like to turn the conference call over to Paul Little, Chief Financial Officer of Eledon.